SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BE7D31A0CF9B9803CD07E8C663BD966138D0EEBFE3797FC349874189C3B587CA2ED0CB4C946A7665F9C25FCEAFAD4D5B>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BE7D31A0CF9B9803CD07E8C663BD966138D0EEBFE3797FC349874189C3B587CA2ED0CB4C946A7665F9C25FCEAFAD4D5B
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BE7D31A0CF9B9803CD07E8C663BD966138D0EEBFE3797FC349874189C3B587CA2ED0CB4C946A7665F9C25FCEAFAD4D5B
http://www.w3.org/2000/01/rdf-schema#comment
"our results offer preclinical proof of concept for the clinical development of IPH4102 a humanized monoclonal antibody that targets the immune receptor KIR3DL2 to treat patients with nced cutaneous T-cell lymphoma"
xsd:string
http://purl.uniprot.org/uniprot/#_BB392A39C80765AC45781B297F6EF8A07E13A71AE07A34A8ECB16D52C6B339D7E138DC8F7B3847E45393A94D04953D20
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BE7D31A0CF9B9803CD07E8C663BD966138D0EEBFE3797FC349874189C3B587CA2ED0CB4C946A7665F9C25FCEAFAD4D5B
http://purl.uniprot.org/uniprot/A0A0G2JM36
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BE7D31A0CF9B9803CD07E8C663BD966138D0EEBFE3797FC349874189C3B587CA2ED0CB4C946A7665F9C25FCEAFAD4D5B
http://purl.uniprot.org/uniprot/#_A0A0G2JM36-mappedCitation-25361998
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BE7D31A0CF9B9803CD07E8C663BD966138D0EEBFE3797FC349874189C3B587CA2ED0CB4C946A7665F9C25FCEAFAD4D5B